Where rare is common
Our breast pathology consultative service receives thousands of cases each year, spanning the spectrum of benign breast disease and diagnostically-challenging atypical lesions to conventional carcinomas and rare variants. We are fortunate to have expansive molecular and immunohistochemistry test menus to aid with diagnosis of rare breast tumors, and to have expertise in breast biomarker and companion diagnostic testing.
breast consult cases seen each year
breast biomarker assays performed each year
Requesting a pathology consult
Our best practices enable expeditious, evidence-based results. Click here to learn more about Mayo Clinic Laboratories consultation request process.
Pathology in Focus
Jodi Carter, M.D., Ph.D., gives an overview of the breast pathology service and the benefits of collaborating with Mayo Clinic Laboratories.
PATHC | Pathology Consultation